COLLAGEN AND JOINT

Natural health product licensed in Canada

Licence holder: GFR Pharma Ltd.
NPN or DIN-HM: 80120515
Status: Active licence
Licence date: 10 August 2022
Revision date: 9 April 2025
Form: Poudre
Route of administration: Orale
Application type: Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Collagène hydrolysé Potency : 167 mg L-Lysine	7,000 mg	Not calculated
Bromélaïne de tige Source : Ananas comosus var. comosus - Tige	486,000 FCC PU	Not calculated
Bromélaïne de tige Source : Ananas comosus var. comosus - Tige	13.5 mg	Not calculated
Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf	500 mg	Not calculated

Non-medicinal ingredients

Saveur de vanille, Extrait de feuilles de stévia

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Portions	1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in maintaining healthy cartilage and/or joint health. Helps protect against the deterioration of cartilage and relieves joint pain associated with osteoarthritis. Helps to protect against the deterioration of cartilage. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Used in herbal medicine to help relieve minor pain, swelling and inflammation. Helps to reduce joint pain associated with osteoarthritis. Source of (the) essential amino acid(s) (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, valine) for the maintenance of good health (and involved in protein synthesis). Source of (the) non-essential amino acid(s) (alanine, arginine, aspartic acid, glutamic acid, glycine, proline, serine, tyrosine) involved in protein synthesis. Source of the essential amino acid lysine to help in collagen formation. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise. Helps to minimize discomfort due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. Starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days). Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.